PAM
GEVA

Panagora Asset Management’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Panagora Asset Management’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-766
Closed -$75K – 2535
2015
Q1 		$75K Buy
+766
New +$81.1K ﹤0.01% 2001

Panagora Asset Management's GEVA Position: Q2 2015 in Review

Panagora Asset Management sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 766 shares — an estimated $75K sold.

Panagora Asset Management first reported a position in GEVA in Q1 2015 and held it in 1 quarter. The position peaked at $75K in Q1 2015. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

  • Panagora Asset Management reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Panagora Asset Management sold 766 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $75K.
  • Panagora Asset Management first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q1 2015 and held it in 1 quarter.
  • Panagora Asset Management's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $75K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on Panagora Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.